These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 23982257

  • 1. Valproic acid sensitizes TRAIL-resistant anaplastic thyroid carcinoma cells to apoptotic cell death.
    Cha HY, Lee BS, Kang S, Shin YS, Chang JW, Sung ES, Kim YS, Choi JW, Kim JH, Kim CH.
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S716-24. PubMed ID: 23982257
    [Abstract] [Full Text] [Related]

  • 2. Downregulation of Nrf2 by the combination of TRAIL and Valproic acid induces apoptotic cell death of TRAIL-resistant papillary thyroid cancer cells via suppression of Bcl-xL.
    Cha HY, Lee BS, Chang JW, Park JK, Han JH, Kim YS, Shin YS, Byeon HK, Kim CH.
    Cancer Lett; 2016 Mar 01; 372(1):65-74. PubMed ID: 26721202
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Proteasome inhibitors synergize with tumor necrosis factor-related apoptosis-induced ligand to induce anaplastic thyroid carcinoma cell death.
    Conticello C, Adamo L, Giuffrida R, Vicari L, Zeuner A, Eramo A, Anastasi G, Memeo L, Giuffrida D, Iannolo G, Gulisano M, De Maria R.
    J Clin Endocrinol Metab; 2007 May 01; 92(5):1938-42. PubMed ID: 17327374
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
    Mitsiades N, Poulaki V, Tseleni-Balafouta S, Koutras DA, Stamenkovic I.
    Cancer Res; 2000 Aug 01; 60(15):4122-9. PubMed ID: 10945619
    [Abstract] [Full Text] [Related]

  • 9. Oxaliplatin sensitizes human colon cancer cells to TRAIL through JNK-dependent phosphorylation of Bcl-xL.
    El Fajoui Z, Toscano F, Jacquemin G, Abello J, Scoazec JY, Micheau O, Saurin JC.
    Gastroenterology; 2011 Aug 01; 141(2):663-73. PubMed ID: 21683075
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Histone deacetylase inhibitors synergistically potentiate death receptor 4-mediated apoptotic cell death of human T-cell acute lymphoblastic leukemia cells.
    Sung ES, Kim A, Park JS, Chung J, Kwon MH, Kim YS.
    Apoptosis; 2010 Oct 01; 15(10):1256-69. PubMed ID: 20582477
    [Abstract] [Full Text] [Related]

  • 12. Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis.
    Siddiqui IA, Malik A, Adhami VM, Asim M, Hafeez BB, Sarfaraz S, Mukhtar H.
    Oncogene; 2008 Mar 27; 27(14):2055-63. PubMed ID: 17998943
    [Abstract] [Full Text] [Related]

  • 13. Trichostatin A sensitizes human ovarian cancer cells to TRAIL-induced apoptosis by down-regulation of c-FLIPL via inhibition of EGFR pathway.
    Park SJ, Kim MJ, Kim HB, Sohn HY, Bae JH, Kang CD, Kim SH.
    Biochem Pharmacol; 2009 Apr 15; 77(8):1328-36. PubMed ID: 19426671
    [Abstract] [Full Text] [Related]

  • 14. Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells.
    Cuello M, Ettenberg SA, Nau MM, Lipkowitz S.
    Gynecol Oncol; 2001 Jun 15; 81(3):380-90. PubMed ID: 11371126
    [Abstract] [Full Text] [Related]

  • 15. R-roscovitine sensitizes anaplastic thyroid carcinoma cells to TRAIL-induced apoptosis via regulation of IKK/NF-kappaB pathway.
    Festa M, Petrella A, Alfano S, Parente L.
    Int J Cancer; 2009 Jun 01; 124(11):2728-36. PubMed ID: 19230027
    [Abstract] [Full Text] [Related]

  • 16. Combined inhibition of DNA methyltransferase and histone deacetylase restores caspase-8 expression and sensitizes SCLC cells to TRAIL.
    Kaminskyy VO, Surova OV, Vaculova A, Zhivotovsky B.
    Carcinogenesis; 2011 Oct 01; 32(10):1450-8. PubMed ID: 21771726
    [Abstract] [Full Text] [Related]

  • 17. Carnitine sensitizes TRAIL-resistant cancer cells to TRAIL-induced apoptotic cell death through the up-regulation of Bax.
    Park SJ, Park SH, Kim JO, Kim JH, Park SJ, Hwang JJ, Jin DH, Jeong SY, Lee SJ, Kim JC, Kim I, Cho DH.
    Biochem Biophys Res Commun; 2012 Nov 09; 428(1):185-90. PubMed ID: 23068102
    [Abstract] [Full Text] [Related]

  • 18. Chetomin induces degradation of XIAP and enhances TRAIL sensitivity in urogenital cancer cells.
    Yano K, Horinaka M, Yoshida T, Yasuda T, Taniguchi H, Goda AE, Wakada M, Yoshikawa S, Nakamura T, Kawauchi A, Miki T, Sakai T.
    Int J Oncol; 2011 Feb 09; 38(2):365-74. PubMed ID: 21165560
    [Abstract] [Full Text] [Related]

  • 19. Efficacy on anaplastic thyroid carcinoma of valproic acid alone or in combination with doxorubicin, a synthetic chenodeoxycholic acid derivative, or lactacystin.
    Kim TH, Yoo YH, Kang DY, Suh H, Park MK, Park KJ, Kim SH.
    Int J Oncol; 2009 May 09; 34(5):1353-62. PubMed ID: 19360347
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of the ubiquitin-proteasome system sensitizes TRAIL-resistant prostate cancer cells by up-regulation of death receptor 5.
    Lee YJ, Seol JW, Jeong JK, Moon MH, Park SY.
    Mol Med Rep; 2011 May 09; 4(6):1255-9. PubMed ID: 21850375
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.